Update information
October 2019: Changes have been made to recommendations 1.9.6, 1.9.9, 1.9.10 and 1.9.11 to reflect new restrictions and precautions for the use of fluoroquinolone antibiotics. These recommendations are labelled [new 2014, amended 2019].
November 2014: recommendation 1.7.7 has been amended to clarify the type of non-steroidal anti-inflammatory drug (NSAID) to be used and that a proton-pump inhibitor should also be prescribed.
September 2014: This guideline updates and replaces NICE guideline CG17 (published in April 2004).
Recommendations are marked as [new 2014], [2014], [2004] or [2004, amended 2014]:
-
[new 2014] indicates that the evidence has been reviewed and the recommendation has been added or updated
-
[2014] indicates that the evidence has been reviewed but no change has been made to the recommended action
-
[2004] indicates that the evidence has not been reviewed since 2004
-
[2004, amended 2014] indicates that the evidence has not been reviewed since 2004, but changes have been made to the recommendation wording that change the meaning.
Minor changes since publication
September 2024: We updated recommendations 1.9.9 and 1.9.10 to reflect the new safety advice on fluoroquinolones.
ISBN: 978-1-4731-0717-5